Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics

被引:88
作者
Ala-Korpela, Mika [1 ]
机构
[1] Aalto Univ, Lab Computat Engn Syst Biol & Bioinformat Technol, Espoo 02015, Hut, Finland
基金
芬兰科学院;
关键词
blood plasma and serum; coronary heart disease; data analysis; diagnostics; lipoprotein subclass; metabolomics; metabonomics; nuclear magnetic resonance spectroscopy; quantification; risk assessment;
D O I
10.1515/CCLM.2008.006
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This review focuses on (i) the current status of H-1 NMR spectroscopy to quantify lipoprotein subclasses directly from serum or plasma, and (ii) the applications of H-1 NMR metabonomics of serum in biomedicine. Related to both themes, experimental and data analysis methodologies are discussed together with the biochemical rationales. Particular emphasis is placed on the concepts of risk assessment and diagnostics in relation to the potential clinical role of H-1 NMR metabonomics; recent applications in the area of coronary heart disease and diabetes are addressed in more detail.
引用
收藏
页码:27 / 42
页数:16
相关论文
共 99 条
[1]   The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent [J].
Ala-Korpela, Mika ;
Lankinen, Niko ;
Salminen, Aino ;
Suna, Teemu ;
Soininen, Pasi ;
Laatikainen, Reino ;
Ingman, Petri ;
Jauhiainen, Matti ;
Taskinen, Marja-Riitta ;
Heberger, Karoly ;
Kaski, Kimmo .
ATHEROSCLEROSIS, 2007, 190 (02) :352-358
[2]   Characterization and molecular detection of atherothrombosis by magnetic resonance-potential tools for individual risk assessment and diagnostics [J].
Ala-Korpela, Mika ;
Sipola, Petri ;
Kaski, Kimmo .
ANNALS OF MEDICINE, 2006, 38 (05) :322-336
[3]   STRUCTURAL-CHANGES OF LIPOPROTEIN LIPIDS BY H-1-NMR [J].
ALAKORPELA, M ;
OJA, J ;
LOUNILA, J ;
JOKISAARI, J ;
SAVOLAINEN, MJ ;
KESANIEMI, YA .
CHEMICAL PHYSICS LETTERS, 1995, 242 (1-2) :95-100
[4]   Quantification of biomedical NMR data using artificial neural network analysis: Lipoprotein lipid profiles from H-1 NMR data of human plasma [J].
AlaKorpela, M ;
Hiltunen, Y ;
Bell, JD .
NMR IN BIOMEDICINE, 1995, 8 (06) :235-244
[5]  
ALAKORPELA M, 1994, J LIPID RES, V35, P2292
[6]   H-1 NMR spectroscopy of human blood plasma [J].
AlaKorpela, M .
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 1995, 27 :475-554
[7]   Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study [J].
Ärnlöv, J ;
Evans, JC ;
Meigs, JB ;
Wang, TJ ;
Fox, CS ;
Levy, D ;
Benjamin, EJ ;
D'Agostino, RB ;
Vasan, RS .
CIRCULATION, 2005, 112 (07) :969-975
[8]  
Bathen TF, 2000, NMR BIOMED, V13, P271, DOI 10.1002/1099-1492(200008)13:5<271::AID-NBM646>3.0.CO
[9]  
2-7
[10]   Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps [J].
Beckonert, O ;
Monnerjahn, K ;
Bonk, U ;
Leibfritz, D .
NMR IN BIOMEDICINE, 2003, 16 (01) :1-11